key: cord-0886473-s8kz1tmb
authors: Pantvaidya, Gouri; Joshi, Shalaka; Nayak, Prakash; Kannan, Sadhana; DeSouza, Ashwin; Poddar, Pabashi; Prakash, Gagan; Vijaykumaran, Preeti; Nair, Deepa; Vaish, Richa; Patkar, Shraddha; Niyogi, Devayani; Joshi, Poonam; Chaudhari, Vikram; Singh, Vikas; Mathews, Saumya; Pramesh, C. S.; Badwe, Rajendra A.; Puri, Ajay
title: Surgical Site Infections in patients undergoing major oncological surgery during the COVID‐19 paNdemic (SCION): A propensity‐matched analysis
date: 2021-11-03
journal: J Surg Oncol
DOI: 10.1002/jso.26738
sha: 68fbb4e8ce43aaa9363c0a18b237d2a619accd61
doc_id: 886473
cord_uid: s8kz1tmb

BACKGROUND AND OBJECTIVES: There are reports of outcomes of elective major cancer surgery during the COVID‐19 pandemic. We evaluated if reinforcement of hand hygiene, universal masking, and distancing as a part of pandemic precautions led to a decrease in the incidence of surgical site infections (SSIs) in major oncologic resections. METHODS: Propensity score matching using the nearest neighbor algorithm was performed on 3123 patients over seven covariates (age, comorbidities, surgery duration, prior treatment, disease stage, reconstruction, and surgical wound type) yielding 2614 matched (pre‐COVID 1612 and COVID 1002) patients. Conditional logistic regression was used to identify if SSI incidence was lower amongst patients operated during the pandemic. RESULTS: There was a 4.2% (p = 0.006) decrease in SSI in patients operated during the pandemic. On multivariate regression, surgery during the COVID‐19 period (odds ratio [OR] = 0.77; 95% confidence interval [CI] = 0.61–0.98; p = 0.03), prior chemoradiation (OR = 2.46; CI = 1.45–4.17; p < 0.001), duration of surgery >4 h (OR = 2.17; 95%CI = 1.55–3.05; p < 0.001) and clean contaminated wounds (OR = 2.50; 95% CI = 1.09–2.18; p = 0.012) were significantly associated with SSI. CONCLUSION: Increased compliance with hand hygiene, near‐universal mask usage, and social distancing during the COVID‐19 pandemic possibly led to a 23% decreased odds of SSI in major oncologic resections. Extending these low‐cost interventions in the post‐pandemic era can decrease morbidity associated with SSI in cancer surgery.

Surgical site infections (SSIs) contribute to significant morbidity in patients undergoing surgery. They increase hospital stay and overall costs of treatment. The direct costs incurred by patients having SSI have been quoted to be approximately two times the costs of an inpatient without SSI. 1 Appropriate hand hygiene principles and reinforcement of sterility practices during in-hospital care have always been the bedrock that has helped surgical departments across various specialties reduce their incidence of SSI. The global pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) necessitated a rapid change of practice in hospitals to protect health care workers and patients to minimize the exposure and the transmission of the virus while continuing to offer "emergency" care and ensuring resources were available to treat the sudden influx of COVID-19 patients.

The first case of the COVID-19 pandemic was reported in India on January 27, 2020. 2 Being a tertiary oncology center, at our hospital, we continued to provide cancer care and perform oncologic surgeries throughout the pandemic. Even though logistic constraints did result in a relative reduction in numbers as part of the COVID-19 pandemic strategy, we recommended and reinforced extended compulsory hand hygiene for all patients, staff, and caregivers across the hospital. 3 We also instituted social distancing and minimized visitors to prevent the transmission of the virus within the hospital.

We hypothesized that strict implementation and repeated reinforcement of these principles during the pandemic, which included increased universal hand sanitization among surgeons, paramedical staff, patients and their caregivers, near-universal usage of masks, and restriction of crowds in the outpatient departments and inpatient wards may have resulted in an overall decrease in the rate of SSIs after cancer surgery.

To validate this hypothesis, we decided to analyze our SSI incidence during the pandemic and perform a matched comparison to a surgical cohort in a non-COVID-19 era.

This study was initiated after Institutional Review Board approval.

The study was initiated after registration with the Clinical Trials Registry of India (CTRI/2020/08/027210). It was a retrospective analysis of prospectively maintained surgical data across various specialized surgical oncology units such as head neck, breast, gynecology, thoracic, GI, bone and soft tissue, neurosurgery, and urology.

Data were retrieved for two time periods: Cohort A (pre-COVID cohort) comprised of patients operated in the pre-COVID period which was from October to December 2019 and Cohort B (COVID cohort) included patients undergoing surgery during the COVID-19 pandemic, from April to June 2020. All patients undergoing elective oncologic surgeries during these two time periods were included.

Patients undergoing emergency procedures and surgeries for infected wounds like wound wash, lavage, and debridement were excluded from the study.

The primary objective of the study was to assess if there was a decreased incidence of SSI in patients undergoing surgery during the COVID-19 pandemic as compared to those who had surgery in the pre-COVID era. We also tried to identify other factors affecting SSI for patients undergoing oncologic surgery.

Demographic data were collected for site of cancer, risk factors for SSI, previous oncologic treatment, details of surgical procedures, COVID-19 testing, and 30-day SSI. Data were obtained from prospectively maintained databases and from hospital electronic medical records. Surgical wounds are routinely classified as clean, clean contaminated, contaminated, and dirty as per the CDC criteria for the classification of surgical wounds and the diagnosis of an SSI and its classification into superficial incisional, deep incisional, and organ space infection was as per the CDC procedure associated module SSI 2020. 4 When feasible, wound swabs were sent for culture and sensitivity testing in patients with suspected SSI. All SSIs were further graded as per the Clavien and Dindo classification. 5 Patients in both cohorts were followed up as per routine follow-up schedules and data were included till 30 days from the date of surgery. There were no changes made in the follow-up schedules for patients operated during the pandemic. The 30-day mortality was also documented.

Depending upon the type and duration of surgery, the antibiotic policy differed in each of the specialty surgical units. However, it was consistent during the two time periods and there was no change instituted in antibiotic policy during the COVID-19 pandemic. Any change in the antibiotic used or prolonged duration for an individual patient was done at the discretion of the treating unit and depended on the occurrence of SSI and/or other systemic infections. Data on change in antibiotic usage and/or prolonged duration were collected for the two data sets. There were no changes in departmental policy on skin/bowel preparation, glycaemic control, wound coverage, or wound handling during the two study periods. year of the current date of surgery. Reconstruction was a combination of microvascular, pedicle, or local flaps where applicable. Factors for PSM were selected a priori by the team of co-investigators, to balance the possible bias of operating patients with early stage tumors, and lesser comorbidities during the COVID-19 pandemic, which would in turn affect the incidence of SSI.

A simple nearest neighbor matching algorithm was used to achieve the best covariate balance after matching, using a caliper of 0.2. Matched data were obtained in a ratio of at least 1 (Cohort B):2(Cohort A). The overall propensity score distribution between the groups was assessed by a Jitter plot ( Figure 1A ). The standardized mean difference (SMD) is the difference in the proportion or means of each covariate between the two cohorts standardized by a standardization factor so that it is on the same scale for all covariates.

SMDs close to zero indicate good balance. Kernel density plots were used to represent standardized differences before and after matching ( Figure 1B) . SMDs before and after matching for each covariate were represented using a Love Plot ( Figure 1C ).

Univariate conditional logistic regression was used to identify factors predicting SSI after obtaining a matched data using propensity score matching (PSM). All factors significant at p < 0.05 were considered for multivariate conditional logistic regression. Effect estimated was represented using odds ratio (OR) along with 95% confidence interval (CI).

All statistical analysis was done using SPSS R Plugins in SPSS ver21 for Windows (SPSS Inc) and STATA 14.0. All p-values (two-sided) less than 0.05 were regarded as statistically significant. ( Table 1 ).

The average blood loss in the two cohorts was 375 and 400 ml, respectively. The average hospital stay was 8.2 days in both cohorts.

Prophylactic COVID testing before surgery was done in 74% of pa- 

There was no significant change in antibiotic usage policy in the two study cohorts with 320 (19.8%) patients in Cohort A versus 181 (18%) in Cohort B patients having either a prolongation or change in antibiotic usage. This was not statistically significant (p = 0.28).

The incidence of SSI in the combined cohorts was 18.4%. This included superficial, deep space, and organ space infections. The incidence was 20.1% for Cohort A and 15.9% for Cohort B. There was a 4.2% (p = 0.006) decrease in the rate of SSI in patients who underwent surgery during the pandemic. Of the SSI, 51% were superficial (251/483) and the rest were a combination of deep and organ space infections. There was a statistically significant decrease in the incidence of superficial SSI (p = 0.003) as compared to deep SSI (p = 0.294) or organ space SSI (p = 0.52). Clavien and Dindo grades I-IIIA constituted 78% of the SSI in the overall data set. A detailed description of the SSI subtypes and the Clavien and Dindo grading in the two study cohorts is shown in Table 2 .

Wound swabs were sent for culture and sensitivity testing in p < 0.001) and clean contaminated surgical wounds (OR = 2.3; 95% CI = 1.7-3.02; p < 0.001) were significantly associated with higher incidence of SSI (Table 3) (Table 4 ).

The COVID-19 pandemic made surgical departments across the globe evolve and implement new policies to enable social distancing, universal use of face masks, and stricter hand hygiene to tackle spread of the SARS COV-2 virus among health care personnel and patients. Similar policies were instituted at our center to reduce the spread of the virus. To validate our hypothesis that the stricter implementation and repeated reinforcement of these policies during the pandemic may have resulted in an overall decrease in the rate of SSI after cancer surgery, we compared two cohorts of patients. To mitigate selection bias in an observational study, that any difference in SSI between the two cohorts could be attributed to less intensive cases and patients with lesser comorbidity being operated during the COVID-19 T A B L E 1 Demographic profile of patients before and after propensity score matching The strength of this study is that it is a single institution cohort with large numbers. Positive wound cultures documented SSI in three-fourths of our patients. All the patients were operated by the same group of surgeons and were operated on during a relatively short time period of nine months thus reducing bias due to differences in surgical skill, technique, protocols followed, and changes in infrastructure or health policy other than those for the COVID-19 pandemic.

We documented a 23% reduction in the odds of developing SSI in major elective oncologic surgeries during the COVID-19 pandemic.

This is most likely due to better implementation of hand hygiene, near-universal use of masks, and physical distancing by doctors, paramedical staff, patients, and caregivers. Although a direct causal link cannot be confirmed by our observational study, reinforcement of hand hygiene and other practices which are implementable interventions without major additional costs or increase in infrastructure, merit attention by surgical departments globally as they may help decrease morbidity after major oncologic procedures.

The study was conceptualized by Gouri Pantvaidya, Ajay Puri, and designed by all authors together. Each author contributed to data collection. Statistical designing and analysis were carried out by Gouri Abbreviations: CI, confidence interval; CT, chemotherapy; OR, odds ratio; RT, radiotherapy; SSI, surgical site infection.

Updated recommendations for control of surgical site infections

First confirmed case of COVID-19 infection in India: a case report

Cancer management in India during COVID-19

Surgical Site Infection (SSI) Event. Center for Disease Control

Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

An introduction to Propensity Score Methods for reducing the effects of confounding in observational studies

Influenza control during the COVID-19 pandemic

Reduction in healthcare-associated respiratory viral infections during a COVID-19 outbreak

COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan

Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses

Impact of lockdown for SARS-CoV-2 (COVID-19) on surgical site infection rates: a monocentric observational cohort study

Development and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection

Surgical site infections in breast surgery: case-control study

Hospital-associated costs due to surgical site infection after breast surgery

Surgical site infection and colorectal surgical procedures: a prospective analysis of risk factors

Risk factors for perineal wound infection after abdominoperineal resection of advanced lower rectal cancer

Risk factors for surgical-site infections after radical gastrectomy for gastric cancer: a study in China

Impact of surgical site infection (SSI) following gynaecological cancer surgery in the UK: a trainee-led multicentre audit and service evaluation

Analysis of surgical site infection after musculoskeletal surgery: Risk assessment using a new scoring system

Risk factors for surgical site-infections in head and neck cancer surgery

Risk factors for surgical site infections after breast surgery: a systematic review and metaanalysis

Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer

Neoadjuvant radiotherapy: a risk factor for short-term wound complications after radical resection for rectal cancer?

Prospective identification of risk factors for wound infection after lower extremity oncologic surgery

Identifying risk factors for surgical site infections in mastectomy patients using the National Surgical Quality Improvement Program database

Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures

Surgical Site Infections in patients undergoing major oncological surgery during the COVID-19 paNdemic (SCION): A propensity-matched analysis